Evox Therapeutics
Evox Therapeutics is a biotechnology company.
Evox Therapeutics has raised €82M across 2 funding rounds from 2 investors, most recently a Series C round in Feb 2021. Based in Oxford, UK; founded 2016; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€82M
€81,639,881
Funding rounds
2
Investors
2
distinct backers
Active since
2019-01
latest 2021-02
Funding by year
EUR raised per yearEvox Therapeutics — funding by year — interactive chart.
Data table
| Evox Therapeutics — funding by year | |
|---|---|
| 2018 | €1.7M |
| 2021 | €80M |
Signals
High confidenceRaise-next likelihood10
base rate 50% for Series C
- ▼ Dormant (no round in 3+ cohort gaps)
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood10
base rate 11% (2+ rounds)
- ▲ €30M+ raised
- ▲ 10y since founding (typical exit age)
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-02-19 | Series C | €80M | Redmile Group | View deal → |
| 2019-01-01 | Other | €1.7M | Innovate UK | View deal → |